Evaluation of Improvements in Patient-reported Quality of Life
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorFundación para la Investigación del Hospital Clínico de Valencia
About this trial
Local intervention trial for the evaluation of improvements in patient-reported Quality of Life and treatment satisfaction, in breast cancer patients (BCP), as a result of flexible treatment planning supported by REBECCA-collected real-world data, in comparison with standard care
Eligibility criteria
Qualifiers
Before patient registration, written informed consent must be given according to national and local regulations.
Participants have had histologically proven stage I-III breast cancer undergoing endocrine treatment (with or without prior chemotherapy) no more than 12 months prior to randomization.
Be between 18 and 75 years of age.
Have increased life expectancy beyond the initial 3 months post-treatment initiation.
Disqualifiers
Patients that are not willing to sign an informed consent form
Trial design
Treatments tested in this trial
- REBECCA system (smartwatch + mobile app use)
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov